Detalhe da pesquisa
1.
Radiation oncologist perceptions of therapeutic cannabis use among cancer patients.
Support Care Cancer
; 29(10): 5991-5997, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33768374
2.
Perception and Utilization of Cannabinoids in Patients Undergoing Radiation Treatment: Our Patients Are Curious.
Int J Radiat Oncol Biol Phys
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38462019
3.
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study.
J Thorac Oncol
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278303
4.
Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer.
Cancers (Basel)
; 15(5)2023 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900386
5.
Prognostic Role of Biologically Active Volume of Disease in Patients With Metastatic Lung Adenocarcinoma.
Clin Lung Cancer
; 24(3): 244-251, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759265
6.
Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the Block.
JCO Precis Oncol
; 7: e2200445, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37656950
7.
Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy.
J Thorac Oncol
; 16(6): 1030-1041, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588109